Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2016-001126-33-GB
EUCTR2016-001126-33-GB
Active, not recruiting
Phase 1

A placebo-controlled double blind, randomised feasibility trial of Desmopressin (DDAVP) in critical illness prior to procedures. - DRIVE - Desmopressin for procedures or Radiological InterVEntions

HS Blood and Transplant0 sites40 target enrollmentSeptember 19, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsOCTIM Injection

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
HS Blood and Transplant
Enrollment
40
Status
Active, not recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 19, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
HS Blood and Transplant

Eligibility Criteria

Inclusion Criteria

  • •Adult patients (age 18 years or above)
  • •Platelet count \=100 x 109/L
  • •Inpatient on a critical care ward
  • •Due to undergo an interventional procedure
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 40
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • •Active bleeding
  • •History of ischaemic heart disease (myocardial infarction or angina), stroke or transient ichaemic attack (TIA)
  • •Admission to ICU with traumatic brain injury or seizures
  • •Congenital bleeding disorder
  • •Pregnant or breastfeeding
  • •History of anaphylaxis to desmopressin

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
DRIVE - Desmopressin for procedures or radiological interventions
ISRCTN12845429HS Blood and Transplant40
Completed
Not Applicable
A feasibility study of octreotide infusion during liver transplantPerioperative bleeding, liver transplantSurgery
ISRCTN17573492niversity College London30
Not yet recruiting
Not Applicable
A double blind, randomized, placebo controlled four way cross-over trial to investigate the effects of metoclopramide on central vasopressin release and HPA-axis activatiodepressionunipolar depressive disorder10027946
NL-OMON31221Centre for Human Drug Research12
Active, not recruiting
Not Applicable
A double blind, randomised, placebo controlled, parallel group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis - N/ASpasticity due to Multiple Sclerosis (MS)
EUCTR2004-002509-63-CZGW Pharma Ltd284
Active, not recruiting
Phase 1
A double blind, randomised, placebo controlled, parallel group study of Sativex in the treratment of subjects with pain due to diabetic neuropathy - N/APainful diabetic neuropathy
EUCTR2004-002530-20-GBGW Pharma Ltd218